Anilinopyrimidines as novel antituberculosis agents

  • Bioorg Med Chem Lett. 2003 May 19;13(10):1755-7. doi: 10.1016/s0960-894x(03)00241-5.
Jody Morgan  1 ,  Rachada Haritakul ,  Paul A Keller
Affiliations
  • 1. Department of Chemistry, University of Wollongong, NSW 2522, Australia.
PMID: 12729658 DOI: 10.1016/s0960-894x(03)00241-5
Abstract

A selection of novel anilinopyrimidine analogues have been found to have micromolar activity against Mycobacterium tuberculosis. This could potentially generate new lead compounds in the fight against multi-drug resistant tuberculosis.